Kategorie: english

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022. The name Avextra emphasises the company’s clear focus on the highest quality cannabis extracts and its commitment to the…

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name.

One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments.

Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.

As one of the leading European vertically-integrated companies developing and manufacturing cannabis based medicines, Eurox Group, based in Hesse, Germany, has successfully fundraised €4,4 Million from new and existing investors at an approximate 62% premium to its July 2021 fundraise.

Eurox Pharma prioritizes research and development. In collaboration with physicians, pharmacists and research, the company aims to produce evidence-based products that meet the specific needs of patients, rather than simply marketing another cannabis product as profitably as possible.

Last year was the year of megarounds for cannabis startups…

Eurox Pharma is a vertically integrated company with roots in the German and European production of herbal medicines. From this tradition, Eurox also ensures the highest quality along the entire value chain for medicinal cannabis extracts and the active ingredient dronabinol.